About
Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. It provides pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile, pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine, 2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino thiophene-3-carbonitrile, 4-amino-2-methyl-10h-thiene benzodiazepine hydrochloride, 2,4-diamino-6-chloropyrimidine, hydronopol, squalene, 5-chloro-3-phenylanthranil, 2-amino-2,5-dichlorobenzophenone, 6-fluoro-3-4-piperidinyl-1,2-benzisoxazole hcl, 3-2-methyl-4H-pyrido pyrimidin-4-one, 4-n-hexyl resorcinol, triazole kopoxil, CAB-60, CABER-4, CAB-70, DTV, avobenzone, nopol, hydronopol, and narwedine. The company also offers active pharmaceuticals ingredients, including voglibose, silodosin, vitamin K2-7, UDCA, P5P, fluralaner, afoxolaner, maropitant, grapiprant, firocoxib, carprofen, loratadine, desloratadine, lamotrigine, gliclazide, and minoxidil. Pharmaids Pharmaceuticals Limited was incorporated in 1989 and is based in Bengaluru, India.
Key Metrics
as of Sep 2026Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.12 | 7.18 | 5.43 | 8.61 | 6.66 | 4.77 | 4.71 | 5.24 | 4.73 | 5.81 | 0.02 | 0.00 | 0.00 |
| Expenses | 4.87 | 7.52 | 7.94 | 13.93 | 12.03 | 8.67 | 7.60 | 7.65 | 8.14 | 11.39 | 2.45 | 1.02 | 1.61 |
| Operating Profit | -0.75 | -0.34 | -2.51 | -5.32 | -5.37 | -3.90 | -2.89 | -2.41 | -3.41 | -5.58 | -2.43 | -1.02 | -1.61 |
| OPM % | -18.20 | -4.74 | -46.22 | -61.79 | -80.63 | -81.76 | -61.36 | -45.99 | -72.09 | -96.04 | -12,150.00 | — | — |
| Other Income | 4.25 | 0.01 | -0.32 | 3.03 | 0.04 | 0.13 | 0.00 | 0.08 | -0.07 | 0.12 | 0.76 | -0.26 | 0.41 |
| Depreciation | 0.49 | 0.48 | 0.48 | 0.47 | 0.61 | 0.62 | 0.64 | 0.61 | 0.57 | 0.63 | 0.04 | 0.01 | 0.01 |
| Interest | 0.60 | 0.65 | 0.72 | 0.93 | 1.20 | 1.01 | 0.48 | 0.33 | 0.26 | 0.77 | 0.02 | 0.00 | 0.00 |
| Profit before tax | 2.41 | -1.46 | -4.03 | -3.69 | -7.14 | -5.40 | -4.01 | -3.27 | -4.31 | -6.86 | -1.73 | -1.29 | -1.21 |
| Tax % | 22.41 | -25.34 | -34.24 | -30.62 | -26.05 | -11.11 | -24.94 | -30.58 | -27.38 | -7.73 | -33.53 | -60.47 | 7.44 |
| Net Profit | 1.88 | -1.09 | -2.65 | -2.57 | -5.27 | -4.80 | -3.01 | -2.27 | -3.12 | -6.33 | -1.15 | -0.50 | -1.30 |
| EPS in Rs | 0.63 | -0.51 | -0.70 | -0.71 | -1.39 | -1.12 | -0.55 | -0.55 | -0.76 | -1.57 | -0.54 | -0.23 | -0.61 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Sales | 27.88 | 19.45 | 15.11 | 0.00 | 3.94 |
| Expenses | 41.39 | 32.20 | 27.46 | 9.89 | 3.81 |
| Operating Profit | -13.51 | -12.75 | -12.35 | -9.89 | 0.13 |
| OPM % | -48.46 | -65.55 | -81.73 | — | 3.30 |
| Other Income | 2.75 | 0.01 | 0.03 | 0.00 | 0.02 |
| Interest | 3.52 | 2.10 | 1.58 | 0.00 | 0.00 |
| Depreciation | 2.03 | 2.44 | 1.72 | 0.02 | 0.01 |
| Profit before tax | -16.31 | -17.28 | -15.62 | -9.91 | 0.14 |
| Tax % | -29.00 | -21.88 | -24.20 | -23.71 | 0.00 |
| Net Profit | -11.57 | -13.51 | -11.85 | -7.56 | 0.15 |
| EPS in Rs | -3.32 | -3.06 | -2.26 | -3.52 | 0.15 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Equity Capital | 35.27 | 35.27 | 35.27 | 21.44 | 10.27 |
| Reserves | 12.39 | 24.05 | 36.78 | 1.02 | -1.60 |
| Borrowings | 23.39 | 38.98 | 8.53 | 0.00 | 0.00 |
| Other Liabilities | 16.21 | 21.54 | 10.75 | 2.13 | 2.44 |
| Total Liabilities | 87.26 | 119.84 | 91.33 | 24.59 | 11.11 |
| Fixed Assets | 53.94 | 76.61 | 63.42 | 0.11 | 0.03 |
| CWIP | 6.10 | 4.53 | 7.00 | 2.00 | 0.45 |
| Investments | 0.00 | 0.00 | 0.00 | 3.31 | 0.00 |
| Other Assets | 27.22 | 38.70 | 20.91 | 19.17 | 10.63 |
| Total Assets | 87.26 | 119.84 | 91.33 | 24.59 | 11.11 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Cash from Operating Activity | -4.06 | -15.11 | -10.62 | -4.02 | -0.26 |
| Cash from Investing Activity | 23.34 | -12.22 | -74.99 | -4.94 | 0.47 |
| Cash from Financing Activity | -19.97 | 23.36 | 77.66 | 21.31 | 0.00 |
| Net Cash Flow | -0.69 | -3.98 | -7.95 | 12.35 | 0.21 |
| Free Cash Flow | 11.05 | -27.37 | -33.33 | -5.69 | -0.26 |
| CFO/OP % | 30.00 | 118.00 | 86.00 | 41.00 | -200.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Debtor Days | 44.90 | 58.74 | 64.74 | — | 124.14 |
| Inventory Days | 8.73 | 346.51 | 111.61 | 0.00 | 90.99 |
| Days Payable | 59.17 | 464.29 | 159.18 | — | 236.18 |
| Cash Conversion Cycle | -5.54 | -59.04 | 17.17 | — | -21.05 |
| Working Capital Days | -172.16 | -160.26 | -68.60 | — | -17.60 |
| ROCE % | -18.48 | -17.43 | -25.99 | -63.67 | — |
Corporate Actions
No corporate actions recorded.